Glioma stem cell treatment with MELK-signaling inhibitors
收藏官方服务：
资源简介：
Glioma stem cell treatment with MELK-signaling inhibitors
应用场景：
创建时间：
2013-08-28
相关数据集
Additional file 13 of Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma
Additional file 13.
DataCite Commons2024-08-18 更新90
Identification and validation of GPD1 as an essential cancer stem cell specific target in glioblastoma (RNA-seq: Gpd1 KO). Identification and validation of GPD1 as an essential cancer stem cell specific target in glioblastoma (RNA-seq: Gpd1 KO)
Cancer stem cells (CSCs) are attractive targets for cancer therapy, however, little is known about how to target CSCs without affecting the normal stem cell population. Here we report the ribosome-pro
NIAID Data Ecosystem70
DataSheet1_Integrated multi-level omics profiling of disulfidptosis identifis SPAG4 as an innovative immunotherapeutic target in glioblastoma.docx
ObjectiveTo investigate the association between disulfidptosis-related genes (DFRGs) and patient prognosis, while concurrently identifying potential therapeutic targets in glioblastoma (GBM). MethodsW
NIAID Data Ecosystem20
Correction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma
Correction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma
NIAID Data Ecosystem80
Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy
Glioblastoma multiforme (GBM) is the most common intracranial cancer but despite recent advances in therapy the overall survival remains about 20 months. Whole genome exon sequencing studies implicate
Figshare2016-01-19 更新20
